Filing Details

Accession Number:
0001104659-22-075786
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-06-29 16:02:05
Reporting Period:
2022-06-27
Accepted Time:
2022-06-29 16:02:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1689375 Entrada Therapeutics Inc. TRDA () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1613084 Dipal Doshi C/O Entrada Therapeutics, Inc.
6 Tide Street
Boston MA 02210
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-06-27 4,000 $12.00 210,710 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 13, 2022.